Ingram, John R., Martina Porter, Raj Chovatiya, Evangelos J. Giamarellos-Bourboulis, Falk G. Bechara, Hideki Fujita, Wayne Gulliver, Edward Muller, Muhammad Bari, Robert Rolleri, Rob Byerly, and Joslyn S Kirby. “Bimekizumab Response Maintenance to 48 Weeks in Patients With Moderate to Severe Hidradenitis Suppurativa: Pooled Responder Analysis from the Phase 3, Double-Blind, Placebo-Controlled, Randomized Clinical Trials BE HEARD I and II”. SKIN The Journal of Cutaneous Medicine 8, no. 2 (March 18, 2024): s396. Accessed July 22, 2024. https://jofskin.org/index.php/skin/article/view/2671.